| payload |
{"created_at":"2026-04-10T14:13:04.518 {"created_at":"2026-04-10T14:13:04.518445+00:00","dedupe_key":"signal_enriched:discovery_new_listings_delta:d42430ae000d2325","evidence_event_ids":["evt_6c29908d13ff"],"signal_type":"discovery_new_listings_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","as_of":"2026-04-10T14:13:04.518445+00:00","canonical_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","article_chars":3602,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_506c104a9543ab03","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T14:23:34.485940+00:00","extraction_method":"heuristic","fetched_description":"In recent trading, shares of ECG (Symbol: ECG) have crossed above the average analyst 12-month target price of $66.33, changing hands for $67.83/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re","fetched_title":"ECG Crosses Above Average Analyst Target | Nasdaq","final_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target","source_event_id":"evt_6c29908d13ff","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"6b2d85929c2fef87","kind":"new_listings","published_at":"2026-04-10T13:20:29+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["December 12, 2024","09:48 am EST","1 Month Ago","2 Month Ago","3 Month Ago"],"entities":[{"asset_class":"equity","name":"Everus Construction Group Inc","relevance":"primary","symbol":"ECG","type":"company"},{"asset_class":"unknown","name":"Zacks Investment Research (via Quandl.com)","relevance":"supporting","symbol":"","type":"data_provider"},{"asset_class":"unknown","name":"BNK Invest","relevance":"supporting","symbol":"","type":"publisher"}],"event_type":"price_action","information_gaps":["The article text provided contains an inconsistency: the headline section shows $129.25 and $130.34/share, while the body text states $66.33 and $67.83/share. The correct values are not resolvable from the provided text alone.","The article does not specify the exact time of the 'crossed above' event beyond the timestamp shown (09:48 am EST).","No underlying fundamental business developments are provided in the excerpt; the discussion of analyst reactions is conditional/interpretive rather than evidence of specific company changes.","The 'Recent ECG Analyst Ratings Breakdown' table is referenced, but the full table values beyond the counts and average rating values shown in the excerpt are not fully detailed."],"key_facts":["The article states ECG crossed above the average analyst 12-month target price.","Average analyst 12-month target cited: $66.33/share.","ECG was cited as changing hands at $67.83/share.","The article says there are 3 different analyst targets within the Zacks coverage universe contributing to the average for ECG.","The article cites one analyst target as low as $58.00 and another as high as $71.00.","The article cites the standard deviation of analyst targets as $7.234.","The article provides an analyst ratings breakdown with counts: Strong buy 2, Buy 0, Hold 3, Sell 0, Strong sell 0 (for the current period shown).","The article includes a table comparing 'Current', '1 Month Ago', '2 Month Ago', and '3 Month Ago' ratings counts and average rating values."],"numeric_claims":[{"label":"Average analyst 12-month target (USD/share)","value":"66.33"},{"label":"ECG trading price cited (USD/share)","value":"67.83"},{"label":"Low analyst target (USD/share)","value":"58.00"},{"label":"High analyst target (USD/share)","value":"71.00"},{"label":"Standard deviation of targets (USD)","value":"7.234"},{"label":"Average rating (current)","value":"2.2"},{"label":"Average rating (1 month ago)","value":"3.0"}],"primary_claim":"ECG crossed above the average analyst 12-month target price of $66.33, trading at $67.83/share.","relevance_score":0.42,"sentiment":"mixed","source_quality":"high","summary":"Everus Construction Group Inc (ECG) traded above the average analyst 12-month target price, with the article citing $67.83/share versus an average target of $66.33/share.","topics":["analyst targets","equity price vs target","Zacks analyst coverage","ratings breakdown"]},"source":"Nasdaq Stocks","source_domain":"nasdaq.com","summary":"In recent trading, shares of Everus Construction Group Inc (Symbol: ECG) have crossed above the average analyst 12-month target price of $129.25, changing hands for $130.34/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: do","tickers":[],"title":"ECG Crosses Above Average Analyst Target","url":"https://www.nasdaq.com/articles/ecg-crosses-above-average-analyst-target"}}... |